Literature DB >> 20566103

Restenosis after carotid endarterectomy: incidence and endovascular management.

G Oszkinis1, F Pukacki, R Juszkat, J B Weigele, M Gabriel, Z Krasinski, M Zieliński, J Krejza.   

Abstract

SUMMARY: Surgical procedures designed to restore vascular patency for a recurrent stenosis following carotid endarterectomy (CEA) are burdened with technical difficulties as well as with the possibility of serious neurological complications. An endovascular approach employing transluminal percutaneous angioplasty and stenting (PTAS) is a promising solution to these problems. We aimed to evaluate the incidence of carotid artery restenosis following CEA, and to evaluate the safety and efficacy of treating post-CEA restenosis with an endovascular technique (PTAS). One hundred and two patients who underwent CEA for symptomatic and asymptomatic stenosis were included in the analysis. Clinical and sonographic follow-up examinations identified carotid artery restenosis in 16 patients, who fulfilled our criteria for endovascular treatment. Carotid PTAS was performed on symptomatic patients with a stenosis over 60% of the artery lumen (n=7) and in asymptomatic patients with a stenosis over 80% (n=9). The post-PTAS patients were evaluated by duplex sonography every three months over a 24 month follow-up period for evidence of restenosis. The cumulative incidence of post-CEA carotid restenosis qualifying for PTAS was 9.3% during an average 12-month follow-up interval. The average time from CEA to carotid PTAS was 11 months. All 16 endovascular procedures were technically successful. All of the carotid arteries were widely patent following PTAS. There were no immediate perioperative complications. One patient died two days after carotid PTAS from a cerebral hemorrhage. Thirteen of the 16 patients remained asymptomatic and had no sonographic evidence of significant restenosis during the 24- month post-PTAS follow-up period. One patient developed a symptomatic 80% restenosis proximal to the stent six months after carotid PTAS. Another patient developed an asymptomatic 60% restenosis proximal to the stent at 24 months. One patient was lost to follow-up. Following CEA, there is a significant risk of developing a symptomatic or high-grade carotid artery restenosis requiring correction. Endovascular treatment (PTAS) of a recurrent stenosis after CEA is a safe and effective alternative to repeat carotid surgery.

Entities:  

Year:  2008        PMID: 20566103      PMCID: PMC3329240          DOI: 10.1177/159101990701300405

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  15 in total

Review 1.  Recurrent carotid stenosis after carotid endarterectomy.

Authors:  C R Lattimer; K G Burnand
Journal:  Br J Surg       Date:  1997-09       Impact factor: 6.939

2.  Scientific evidence demonstrating the safety of carotid angioplasty and stenting: do we have enough to draw conclusions yet?

Authors:  H G Beebe
Journal:  J Vasc Surg       Date:  1998-04       Impact factor: 4.268

3.  Angioplasty and stenting for restenosis after carotid endarterectomy. Initial experience.

Authors:  J S Yadav; G S Roubin; P King; S Iyer; J Vitek
Journal:  Stroke       Date:  1996-11       Impact factor: 7.914

4.  Carotid artery stenosis following endarterectomy.

Authors:  R E Zierler; D F Bandyk; B L Thiele; D E Strandness
Journal:  Arch Surg       Date:  1982-11

Review 5.  Current status of carotid bifurcation angioplasty and stenting based on a consensus of opinion leaders.

Authors:  F J Veith; M Amor; T Ohki; H G Beebe; P R Bell; A Bolia; P Bergeron; J J Connors; E B Diethrich; R D Ferguson; M Henry; R W Hobson; L N Hopkins; B T Katzen; K Matthias; G S Roubin; J Theron; M H Wholey; S S Yadav
Journal:  J Vasc Surg       Date:  2001-02       Impact factor: 4.268

6.  Routine surveillance after carotid endarterectomy: does it affect clinical management?

Authors:  M A Mattos; P S van Bemmelen; L D Barkmeier; K J Hodgson; D E Ramsey; D S Sumner
Journal:  J Vasc Surg       Date:  1993-05       Impact factor: 4.268

7.  Impact of carotid artery angioplasty and stenting on management of recurrent carotid artery stenosis.

Authors:  Caron B Rockman; Danielle Bajakian; Glenn R Jacobowitz; Thomas Maldonado; Uri Greenwald; Matthew M Nalbandian; Mark A Adelman; Paul J Gagne; Patrick J Lamparello; Roninie M Landis; Thomas S Riles
Journal:  Ann Vasc Surg       Date:  2004-03       Impact factor: 1.466

8.  Residual lesions and early recurrent stenosis after carotid endarterectomy. A serial follow-up study with duplex scanning and intravenous digital subtraction angiography.

Authors:  E A Sanders; H Hoeneveld; B C Eikelboom; J W Ludwig; F E Vermeulen; R G Ackerstaff
Journal:  J Vasc Surg       Date:  1987-05       Impact factor: 4.268

9.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.

Authors:  H J M Barnett; D W Taylor; R B Haynes; D L Sackett; S J Peerless; G G Ferguson; A J Fox; R N Rankin; V C Hachinski; D O Wiebers; M Eliasziw
Journal:  N Engl J Med       Date:  1991-08-15       Impact factor: 91.245

10.  Natural history of recurrent carotid artery disease.

Authors:  A V Sterpetti; R D Schultz; R J Feldhaus; W J Hunter; R T Bailey; K Hacker; K L Davenport; M Richardson
Journal:  Surg Gynecol Obstet       Date:  1989-03
View more
  3 in total

1.  Long-term Comparative Outcomes of Carotid Artery Stenting Following Previous Carotid Endarterectomy vs De Novo Lesions.

Authors:  Albeir Y Mousa; Ali F AbuRahma; Joseph Bozzay; Mike Broce; Maher Kali; Michael Yacoub; Patrick Stone; Mark C Bates
Journal:  J Endovasc Ther       Date:  2015-04-15       Impact factor: 3.487

2.  Asymptomatic dissecting intimal lesions of common carotid arteries after carotid endarterectomy.

Authors:  Hrvoje Budincevic; Ante Ivkosic; Miran Martinac; Tomislav Trajbar; Ivan Bielen; Laszlo Csiba
Journal:  Surg Today       Date:  2014-08-27       Impact factor: 2.549

Review 3.  Bench-to-Bedside in Vascular Medicine: Optimizing the Translational Pipeline for Patients With Peripheral Artery Disease.

Authors:  Tom Alsaigh; Belinda A Di Bartolo; Jocelyne Mulangala; Gemma A Figtree; Nicholas J Leeper
Journal:  Circ Res       Date:  2021-06-10       Impact factor: 23.213

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.